• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.

作者信息

Aronis Konstantinos N, Hylek Elaine M

机构信息

Division of Cardiology, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, Baltimore, MD

Section of General Internal Medicine, Boston Medical Center, Boston University School of Medicine, Boston, MA.

出版信息

J Am Heart Assoc. 2018 Jan 26;7(3):e007338. doi: 10.1161/JAHA.117.007338.

DOI:10.1161/JAHA.117.007338
PMID:29374049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5850242/
Abstract
摘要

相似文献

1
Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.非维生素K口服抗凝剂时代的证据空白
J Am Heart Assoc. 2018 Jan 26;7(3):e007338. doi: 10.1161/JAHA.117.007338.
2
Management of Venous Thromboembolism in the Elderly: A Review of the Non-Vitamin K Oral Anticoagulants.老年静脉血栓栓塞症的管理：非维生素K口服抗凝剂综述
Consult Pharm. 2018 May 1;33(5):248-261. doi: 10.4140/TCP.n.2018.248..
3
Direct oral anticoagulants and venous thromboembolism.直接口服抗凝剂与静脉血栓栓塞症
Eur Respir Rev. 2016 Sep;25(141):295-302. doi: 10.1183/16000617.0025-2016.
4
Bleeding in patients receiving non-vitamin K oral anticoagulants: clinical trial evidence.接受非维生素K口服抗凝剂治疗患者的出血情况：临床试验证据
Ther Adv Cardiovasc Dis. 2018 Dec;12(12):361-380. doi: 10.1177/1753944718801554. Epub 2018 Sep 30.
5
Non-Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves: Is the Door Still Open?机械心脏瓣膜的非维生素 K 拮抗剂口服抗凝剂：这扇门是否仍然敞开？
Circulation. 2018 Sep 25;138(13):1356-1365. doi: 10.1161/CIRCULATIONAHA.118.035612.
6
A review of oral anticoagulants, old and new, in major bleeding and the need for urgent surgery.新旧口服抗凝剂在大出血和紧急手术中的应用综述。
Trends Cardiovasc Med. 2020 Feb;30(2):86-90. doi: 10.1016/j.tcm.2019.03.004. Epub 2019 Mar 26.
7
Use of direct oral anticoagulants in antiphospholipid syndrome.抗磷脂综合征中直接口服抗凝剂的应用。
J Thromb Haemost. 2018 Jun;16(6):1028-1039. doi: 10.1111/jth.14017. Epub 2018 May 13.
8
New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons.新型口服抗凝剂治疗急性静脉血栓栓塞症——一项间接比较的系统评价
Vasa. 2014 Sep;43(5):353-64. doi: 10.1024/0301-1526/a000373.
9
Drugs for treatment and prevention of venous thromboembolism.用于治疗和预防静脉血栓栓塞的药物。
Med Lett Drugs Ther. 2018 Mar 12;60(1542):41-48.
10
Anticoagulation reversal in the era of the non-vitamin K oral anticoagulants.非维生素K口服抗凝剂时代的抗凝逆转
Europace. 2016 Jul;18(7):955-64. doi: 10.1093/europace/euv030. Epub 2015 Mar 26.

引用本文的文献

1
Current practices and challenges in the management of cancer-associated thrombosis: a survey of Italian oncologists.癌症相关血栓管理的当前实践与挑战：一项针对意大利肿瘤学家的调查
Front Oncol. 2025 Aug 6;15:1579464. doi: 10.3389/fonc.2025.1579464. eCollection 2025.
2
Management of severe traumatic brain injury in a rivaroxaban overdose: illustrative case.利伐沙班过量导致严重创伤性脑损伤的处理：病例说明
J Neurosurg Case Lessons. 2024 Dec 2;8(23). doi: 10.3171/CASE24475.
3
Efficacy and Safety of Andexanet Alfa Versus Four Factor Prothrombin Complex Concentrate for Emergent Reversal of Factor Xa Inhibitor Associated Intracranial Hemorrhage: A Systematic Review and Meta-Analysis.与四因子凝血酶原复合物浓缩物相比，andexanet alfa用于紧急逆转Xa因子抑制剂相关颅内出血的疗效和安全性：一项系统评价和荟萃分析。
Neurocrit Care. 2025 Apr;42(2):701-714. doi: 10.1007/s12028-024-02130-y. Epub 2024 Oct 8.
4
Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m) with Atrial Fibrillation or Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis.直接口服抗凝剂与华法林用于肥胖（体重指数≥30 kg/m²）房颤或静脉血栓栓塞患者的疗效及安全性：一项更新的系统评价和荟萃分析
J Clin Med. 2024 Jun 27;13(13):3784. doi: 10.3390/jcm13133784.
5
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study.直接口服抗凝剂在合并贫血和/或血小板减少症的心房颤动患者卒中预防中的安全性和有效性：一项回顾性队列研究
Thromb J. 2023 Nov 21;21(1):118. doi: 10.1186/s12959-023-00563-7.
6
Management of Patients Treated with Direct Oral Anticoagulants in Clinical Practice and Challenging Scenarios.临床实践及复杂情况下接受直接口服抗凝剂治疗患者的管理
J Clin Med. 2023 Sep 13;12(18):5955. doi: 10.3390/jcm12185955.
7
Pharmacokinetics and Dosing Regimens of Direct Oral Anticoagulants in Morbidly Obese Patients: An Updated Literature Review.肥胖患者直接口服抗凝剂的药代动力学和给药方案：最新文献综述。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231153638. doi: 10.1177/10760296231153638.
8
Direct Oral Anticoagulants versus Vitamin K Antagonists in Individuals Aged 80 Years and Older: An Overview in 2021.直接口服抗凝剂与维生素 K 拮抗剂在 80 岁及以上人群中的应用：2021 年概述。
Int J Environ Res Public Health. 2023 Jan 13;20(2):1448. doi: 10.3390/ijerph20021448.
9
Adherence to Antithrombotic Therapy for Patients Attending a Multidisciplinary Thrombosis Service in Canada - A Cross-Sectional Survey.加拿大多学科血栓形成服务机构患者对抗血栓治疗的依从性——一项横断面调查
Patient Prefer Adherence. 2022 Jul 26;16:1771-1780. doi: 10.2147/PPA.S367105. eCollection 2022.
10
Direct oral anticoagulants in sickle cell disease: a systematic review and meta-analysis.镰状细胞病中的直接口服抗凝剂：一项系统评价和荟萃分析。
Blood Adv. 2022 Sep 13;6(17):5061-5066. doi: 10.1182/bloodadvances.2022007308.

本文引用的文献

1
Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data.新诊断且未经治疗的房颤患者使用利伐沙班、达比加群和阿哌沙班预防卒中的依从性：基于 2013-2014 年数据的更新。
J Manag Care Spec Pharm. 2017 Sep;23(9):958-967. doi: 10.18553/jmcp.2017.23.9.958.
2
Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动患者中利伐沙班与其他口服抗凝药物的依从性比较。
J Manag Care Spec Pharm. 2017 Sep;23(9):980-988. doi: 10.18553/jmcp.2017.23.9.980.
3
In-vitro assessment of the effect of dabigatran on thrombosis of adult and neonatal plasma: comparisons using thromboelastography and microscopic visualization of fibrin clot structure.达比加群对成人及新生儿血浆血栓形成影响的体外评估：使用血栓弹力图和纤维蛋白凝块结构显微镜观察的比较
Blood Coagul Fibrinolysis. 2017 Oct;28(7):551-557. doi: 10.1097/MBC.0000000000000639.
4
Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants.服用华法林个体中严重肾功能不全的发生率及其对非维生素K口服抗凝剂的影响。
Am Heart J. 2017 Feb;184:150-155. doi: 10.1016/j.ahj.2016.08.017. Epub 2016 Nov 4.
5
Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry.非维生素 K 拮抗剂口服抗凝剂的标签外剂量与不良结局：ORBIT-AF II 注册研究。
J Am Coll Cardiol. 2016 Dec 20;68(24):2597-2604. doi: 10.1016/j.jacc.2016.09.966.
6
Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study.利伐沙班用于治疗癌症相关静脉血栓栓塞性疾病的安全性和有效性：一项前瞻性队列研究。
J Thromb Thrombolysis. 2017 Feb;43(2):166-171. doi: 10.1007/s11239-016-1429-1.
7
Direct oral anticoagulants (DOACs) and pregnancy: A plea for better information.直接口服抗凝剂（DOACs）与妊娠：呼吁提供更完善的信息。
Thromb Haemost. 2016 Sep 27;116(4):590-1. doi: 10.1160/TH16-08-0602. Epub 2016 Aug 25.
8
Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study.非维生素K拮抗剂口服抗凝药的使用未达最佳效果：RAMSES研究结果
Medicine (Baltimore). 2016 Aug;95(35):e4672. doi: 10.1097/MD.0000000000004672.
9
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.利伐沙班与华法林治疗血栓形成性抗磷脂综合征患者（无论是否合并系统性红斑狼疮）（RAPS）：一项随机、对照、开放标签的2/3期非劣效性试验。
Lancet Haematol. 2016 Sep;3(9):e426-36. doi: 10.1016/S2352-3026(16)30079-5.
10
Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?美国处方模式评估：癌症相关静脉血栓栓塞的治疗指南是否得到遵循？
Thromb Res. 2016 Sep;145:51-3. doi: 10.1016/j.thromres.2016.07.013. Epub 2016 Jul 26.